Preparation method of adefovir dipivoxil

A technology of adefovir dipivoxil and ethyl acetate, applied in the field of drug synthesis, can solve the problems of unfavorable use of physical properties, unfavorable environmental protection, high production cost, etc.

Active Publication Date: 2016-06-08
BEIJING YUEKANGKECHUANG PHARM TECH CO LTD
View PDF5 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] U.S. Patents US4724233 and US4808716, European Patent EP481214, J.Med.Chem (1994) 37:1857-1864 and many other documents disclose 9-[2-[[[bis(trimethylacetoxy)methyl]phosphine Base] methoxy]-ethyl] adenine and preparation method thereof, all prepared are amorphous form, its physical properties are not conducive to subsequent use, and the melting point is uncertain, poor fluidity and difficult to prepare; some solvents High toxicity, which is not conducive to environmental protection; the resulting product has low purity and low yield, and the production cost is high

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation method of adefovir dipivoxil
  • Preparation method of adefovir dipivoxil
  • Preparation method of adefovir dipivoxil

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0035] Synthesis of 9-[2-[[[[bis(trimethylacetoxy)methyl]phosphoryl]methoxy]-ethyl]adenine

[0036] Add 55g of adefovir into the flask, add 200ml of N-methylpyrrolidone, add 160ml of chloromethyl pivalate, 90ml of triethylamine, 65g of tetra-n-butylammonium bromide, heat up to 55-65°C for 3h, The reaction is complete when the main peak area is 60% detected by high-performance liquid phase. Add 700ml of ethyl acetate, stir and dissolve for 30min, filter, and wash with 220ml of ethyl acetate for 3 times until the filter cake is white. The filtrate is washed with saturated saline 550ml* 3 times, discard the water phase, dry the organic phase with 110g of anhydrous sodium sulfate for 2h, filter, remove the anhydrous sodium sulfate, and wash the filter cake with 50ml of ethyl acetate, and concentrate the filtrate under reduced pressure at 40-50°C to light yellow viscous 600ml of diethyl ether was added under stirring at 10-15°C. After crystals were precipitated, it was filtered, wa...

Embodiment 2

[0038] Add 55g of adefovir into the flask, add 200ml of DMF, add 160ml of chloromethyl pivalate, 90ml of triethylamine, 45g of tetra-n-propylammonium bromide, raise the temperature to 55-65°C for 3 hours, and detect it by high performance liquid phase The main peak area is 63% and the reaction is complete. Add 700ml of ethyl acetate, stir and dissolve for 30min, filter, and wash with 220ml of ethyl acetate for 3 times until the filter cake is white, wash the filtrate with saturated saline 550ml*3 times, discard The aqueous phase and the organic phase were dried with 110g of anhydrous sodium sulfate for 2h, filtered to remove the anhydrous sodium sulfate, and washed the filter cake with 50ml of ethyl acetate, and the filtrate was concentrated under reduced pressure at 40-50°C to a light yellow viscous liquid, 10- 600ml of diethyl ether was added under stirring at 15°C, after crystals were precipitated, filtered, washed with 50ml of diethyl ether, and vacuum-dried at 40-50°C for ...

Embodiment 3

[0040] Add 55g of adefovir into the flask, add 200ml of DMSO, add 160ml of chloromethyl pivalate, 90ml of triethylamine, 55g of tetra-n-ethylammonium iodide, heat up to 55-65°C for 5 hours, and detect The main peak area is 65% and the reaction is complete. Add 700ml of ethyl acetate, stir to dissolve for 30min, filter, and wash with 220ml of ethyl acetate for 3 times until the filter cake is white. Wash the filtrate with saturated saline 550ml*3 times, discard The aqueous phase and the organic phase were dried with 110g of anhydrous sodium sulfate for 2h, filtered to remove the anhydrous sodium sulfate, and washed the filter cake with 50ml of ethyl acetate, and the filtrate was concentrated under reduced pressure at 40-50°C to a light yellow viscous liquid, 10- 600ml of diethyl ether was added under stirring at 15°C, after crystals were precipitated, filtered, washed with 50ml of diethyl ether, and vacuum-dried at 40-50°C for 4 hours to obtain 56g of adefovir dipivoxil with a y...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a preparation method of adefovir dipivoxil. The preparation method includes: adopting N-methyl pyrrolidone as a solvent, tetra-n-butylammonium bromide as a phase transfer catalyst, triethylamide as an acid adsorbent and adefovir and chloromethyl pivalate as raw materials to prepare 9-{2-{{{di(trimethylacetoxy)methyl}phosphoroso}methoxy}-ethyl)adenine. The preparation method is safe, environment-friendly and controllable in reaction, high in economic benefit and more suitable for industrial production.

Description

technical field [0001] The present invention relates to a drug synthesis method, in particular to a medicine for treating chronic hepatitis B 9-[2-[[[[bis(trimethylacetoxy)methyl]phosphoryl]methoxy]-ethyl] The preparation method of adenine. Background technique [0002] The chemical structural formula of Adefovir Dipivoxil (AD) is: [0003] [0004] The chemical name is 9-[2-[[[[bis(trimethylacetoxy)methyl]oxonyl]methoxy]-ethyl]adenine, which can effectively treat HIV-infected patients, and its toxicity is relatively Low, it can also be used as the initial treatment of chronic hepatitis B (HBV) or combined with other anti-HBV drugs. [0005] 9-[2-[[[[bis(trimethylacetoxy)methyl]oxophosphoryl]methoxy]-ethyl]adenine has been approved by China SFDA for the treatment of chronic hepatitis B, and its indications are Adult patients with chronic hepatitis B with compensated liver function. This drug is especially suitable for those who need long-term medication or have develo...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & AuthorityApplications(China)
IPC IPC(8): C07F9/6561
CPCC07F9/65616
Inventor郭勇石红燕彭浩然李延君
OwnerBEIJING YUEKANGKECHUANG PHARM TECH CO LTD